# Successful Hemispherotomy in a Patient With 22q11.2 Deletion Syndrome Who Had Developmental and Epileptic Encephalopathy With Spike-and-Wave Activation During Sleep

**Authors:** Naoki Yamada, Ichiro Kuki, Takehiro Uda, Shin Okazaki

PMC · DOI: 10.7759/cureus.58424 · Cureus · 2024-04-16

## TL;DR

A child with a genetic disorder and severe brain condition improved after surgery to remove part of the brain, reducing seizures and improving development.

## Contribution

Demonstrates successful hemispherotomy in a patient with 22q11.2 deletion syndrome and developmental epileptic encephalopathy.

## Key findings

- Hemispherotomy eliminated seizures and spike-and-wave activity during sleep.
- Cognitive and developmental improvements were observed post-surgery.
- Surgical intervention is viable for drug-resistant epilepsy in chromosomal disorder patients.

## Abstract

We report a case of developmental and epileptic encephalopathy with spike-and-wave activation during sleep with 22q11.2 deletion syndrome in a patient who had undergone hemispherotomy and achieved developmental improvement. A four-year-old male child with paralysis on the left side of his body since birth had a mild developmental delay. An MRI of the brain revealed polymicrogyria diffusely throughout the right hemisphere. He was diagnosed with the 22q11.2 deletion syndrome at one year of age. Focal impaired awareness seizure in the right hemisphere origin and focal to bilateral tonic-clonic seizure appeared by two years of age. At three years of age, myoclonic seizures occurred, which induced frequent falls. Simultaneously, developmental and epileptic encephalopathy with spike-and-wave activation during sleep were observed. At four years and seven months of age, the patient underwent a right hemispherotomy. Epileptic seizures and spike-and-wave activation during sleep disappeared, and cognitive improvement was observed one year after surgery. In spite of chromosomal abnormalities being present, drug-resistant epilepsy with localized regions on MRI should be evaluated to determine surgical options to improve cognitive function and development.

## Linked entities

- **Diseases:** 22q11.2 deletion syndrome (MONDO:0008564), developmental and epileptic encephalopathy (MONDO:0100062)

## Full-text entities

- **Diseases:** drug-resistant epilepsy (MESH:D000069279), polymicrogyria (MESH:D065706), impaired awareness seizure (MESH:D058926), chromosomal abnormalities (MESH:D002869), paralysis (MESH:D010243), Developmental and Epileptic Encephalopathy (MESH:C562695), myoclonic seizures (MESH:D012640), Epileptic seizures (MESH:D004827), developmental delay (MESH:D002658), 22q11.2 Deletion Syndrome (MESH:D004062)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11098713/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11098713/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC11098713/full.md

---
Source: https://tomesphere.com/paper/PMC11098713